Nichole Escalante, PhDSenior Scientist and Group Lead at ZymeworksSpeaker
Profile
Dr. Nichole Escalante earned her PhD in Immunology from the University of Toronto and completed postdoctoral training at Stanford University, focusing on immune cell-engaging therapies for cancer and autoimmunity.
She is a Senior Scientist and Group Lead of the In Vivo Pharmacology and Pharmacokinetics team within Zymeworks' Multispecific Antibody Therapeutics department. She provides scientific and strategic leadership in the preclinical evaluation of antibody- and cytokine-based therapeutics, overseeing assay and model development to characterize therapeutic activity and pharmacokinetics. She also leads cross-functional therapeutic development efforts, shaping preclinical strategy and driving the advancement of novel therapeutic candidates.
Agenda Sessions
Engineering Conditional Co-stimulation: Key Considerations for Developing Next-Generation T Cell Engagers
, 1:45pmView Session
